Main Session: Nuances in the Management of Aggressive Lymphomas

What is the role of immunotherapy in aggressive lymphoma? What do APs need to know about managing immune-related adverse events in patients?

Paul Hamlin, MD
Memorial Sloan Kettering Cancer Center

Michelle R. Wisniewski, MS, PA-C
Memorial Sloan Kettering Cancer Center

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here